1. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study;Hart,2019
2. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes;Johnston,2012
3. Management of secondary genomic findings;Katz,2020
4. Evaluation of recipients of positive and negative secondary findings evaluations in a hybrid CLIA-research sequencing pilot;Sapp,2018
5. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing;Green,2013